Genetic Evaluation of Localized Prostate Cancer in a Cohort of Forty Patients: Gain Of Distal 8q Discriminates Between Progressors and Nonprogressors [PDF]
Herman van Dekken+10 more
openalex +1 more source
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen+13 more
wiley +1 more source
Imputation of non-genotyped F1 dams to improve genetic gain in swine crossbreeding programs. [PDF]
See GM, Fix JS, Schwab CR, Spangler ML.
europepmc +1 more source
Effect of accuracy of contemporary averages on the expected genetic gain from selection
E. Bruns
openalex +2 more sources
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha+6 more
wiley +1 more source
The Effect of Using Organic or Conventional Sires on Genetic Gain in Organic Pigs: A Simulation Study. [PDF]
Zaalberg RM+5 more
europepmc +1 more source
Potential Genetic Gains from Producing Bulls with Only Sires as Parents
P. M. van Raden, A.E. Freeman
openalex +1 more source
Maximizing genetic gain over multiple generations with quantitative trait locus selection and control of inbreeding1 [PDF]
Beatriz Villanueva+3 more
openalex +1 more source
Gaining Ground in the Genetics of Gastric Cancer [PDF]
openaire +3 more sources
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini+11 more
wiley +1 more source